Comparison of the effect of fluocinolone drug with oral atorvastatin on the treatment of patients with vitiligo

Phase 3

Recruiting

• Conditions: Vitiligo.; Vitiligo

• Registration Number: IRCT20151228025732N64
• Lead Sponsor: Semnan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age 20-60 years
Infection of less than 20% of the body surface with vitiligo
Vitiligo over the past year

Exclusion Criteria

Pregnant or lactating woman
With systemic and metabolic diseases (diabetes, thyroid diseases, etc.)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of the disease. Timepoint: Before intervention, 1 and 2 months after intervention. Method of measurement: Scoring using the vitiligo area severity index (VASI) and clinical examination.